Actively Recruiting
Mass Vaccine and Drug Administration, Bangladesh
Led by University of Oxford · Updated on 2025-12-18
10000
Participants Needed
2
Research Sites
154 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an open i.e. not blinded, cluster-randomised, controlled intervention study. The study will use a factorial design to estimate the protective effectiveness of mass drug administrations, mass vaccinations, combined mass vaccinations and drug administrations versus the current standard of care.
CONDITIONS
Official Title
Mass Vaccine and Drug Administration, Bangladesh
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Current residence in a study village irrespective of permanence
- Age 6 months and above (no upper age limit)
- Written informed consent provided by participants or parent/guardian if under 18 years old
You will not qualify if you...
- Pregnancy, plan to get pregnant, or breastfeeding
- Acute illness requiring intervention
- History of adverse reaction to study drugs or vaccine
- Prior receipt of any other malaria vaccine
- Enrollment in another intervention trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Alikadam Upazila Health Complex
Bāndarban, Bangladesh, 4650
Actively Recruiting
2
Lama Upazila Health Complex
Lāma, Bangladesh, 4641
Actively Recruiting
Research Team
L
Lorenz von Seidlein
CONTACT
R
Rupam Tripura
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here